| Members |
targetComponentId |
| Lymphosarcoma of intrathoracic lymph nodes |
Mixed cell type lymphosarcoma of intrathoracic lymph nodes (disorder) |
| Lymphosarcoma of lymph nodes of axilla AND/OR upper limb |
Non-Hodgkin's lymphoma (clinical) |
| Lymphosarcoma of lymph nodes of head, face AND/OR neck (disorder) |
Non-Hodgkin's lymphoma (clinical) |
| Lymphosarcoma of lymph nodes of inguinal region AND/OR lower limb |
Non-Hodgkin's lymphoma (clinical) |
| Lymphosarcoma of lymph nodes of multiple sites |
Malignant lymphoma of lymph nodes |
| Lymphosarcoma of spleen |
Non-Hodgkin's lymphoma (clinical) |
| frystorkat pulver till injicerbar liposomsuspension |
Lyophilized powder for conventional release suspension for injection (dose form) |
| lypressinallergi |
Allergy to antidiuretic hormone |
| Lysis of adhesions of abdomen |
Lysis of adhesions of peritoneum |
| Lückenschadel |
Craniolacunia |
| M+nage E trois |
Ménage à trois |
| MV |
megavolt (qualifier value) |
| Machine tool operator |
Machine-tool operator (general) |
| makrill, livsmedel |
Mackerel (substance) |
| överdos av makrolid |
Macrolide antibacterial overdose (disorder) |
| mafenidacetat 5 %, pulver |
Product containing only mafenide (medicinal product) |
| mafenidacetat 85 mg/g, hudkräm |
Product containing precisely mafenide (as mafenide acetate) 85 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
| mafenidacetat 85 mg/g, kräm |
Product containing precisely mafenide (as mafenide acetate) 85 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
| Magaldrate 800mg/5mL suspension |
Product containing precisely magaldrate 80 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Magnesium aspartate hydrochloride |
Product containing magnesium aspartate (medicinal product) |
| magnesiumklorid 200 mg/ml, injektionsvätska, lösning, ampull |
Product containing only magnesium chloride in parenteral dose form (medicinal product form) |
| magnesiumcitratpulver 17,7 g, dospåse |
Product containing only magnesium citrate (medicinal product) |
| magnesiumsalicylat 467 mg, kapseltablett |
Product containing only magnesium salicylate in oral dose form (medicinal product form) |
| magnesiumsalicylat 467 mg, tablett |
Product containing only magnesium salicylate in oral dose form (medicinal product form) |
| magnesiumsalicylat 500 mg, kapseltablett |
Product containing only magnesium salicylate in oral dose form (medicinal product form) |
| magnesiumsalicylat 500 mg, tablett |
Product containing only magnesium salicylate in oral dose form (medicinal product form) |
| magnesiumtillägg |
Magnesium compound |
| magnesiumtrisilikat + belladonna 0,15 mg, tablett |
Belladonna alkaloid and magnesium trisilicate only product |
| magnesiumbaserat antacidum |
Magnesium compound |
| Major amblyoscope |
Major amblyoscope (physical object) |
| klinisk handläggningsplan för egentlig depression |
Major depressive disorder clinical management plan |
| större puerperal infektion |
Postnatal infection |
| ringer obscena telefonsamtal |
Telephone scatologia |
| malation 1 %, krämschampo |
Malathion 10 mg/mL shampoo |
| manlig erektionsstörning |
Erectile dysfunction |
| peritonit i manligt bäcken |
Pelvic peritonitis |
| extrakt specifikt för maleinsyraanhydrid |
Maleic anhydride |
| malign adenomatös tumör, kategori |
Malignant adenomatous neoplasm (morphologic abnormality) |
| malign epitelial tumör, kategori |
Malignant epithelial neoplasm |
| malign fibrohistiocytär tumör, kategori |
Malignant fibrohistiocytic neoplasm (morphologic abnormality) |
| malignt gliom, kategori |
Glioma, malignant (morphologic abnormality) |
| malign histiocytär tumör |
Malignant histiocytic neoplasm (morphologic abnormality) |
| Malignant histiocytosis |
Malignant histiocytosis |
| Malignant hypothermia due to anesthetic |
Hypothermia caused by anesthetic (finding) |
| malignt lymfangiom |
Lymphangiosarcoma |
| malignt lymfom, kategori |
Malignant lymphoma |
| Malignant lymphoma, centroblastic, diffuse |
Diffuse large B cell malignant lymphoma (morphologic abnormality) |
| Malignant lymphoma, centroblastic-centrocytic, diffuse |
Malignant lymphoma, mixed small and large cell, diffuse |
| Malignant lymphoma, centrocytic |
Mantle cell lymphoma |
| Malignant lymphoma, diffuse |
Non-Hodgkin lymphoma |
| malignt storcelligt B-cellslymfom, diffust |
Diffuse large B cell malignant lymphoma (morphologic abnormality) |
| Malignant lymphoma, large cell, cleaved, diffuse |
Diffuse large B cell malignant lymphoma (morphologic abnormality) |
| Malignant lymphoma, large cell, noncleaved, diffuse |
Diffuse large B cell malignant lymphoma (morphologic abnormality) |
| Malignant lymphoma, lymphoblastic |
Precursor cell lymphoblastic lymphoma |
| Malignant lymphoma, lymphocytic, intermediate differentiation, nodular |
Non-Hodgkin lymphoma |
| Malignant lymphoma, lymphocytic, poorly differentiated, nodular |
Follicular lymphoma, grade 1 |
| malignt lymfom |
Malignant lymphoma |
| Malignant lymphoma, small cell, noncleaved, diffuse |
Non-Hodgkin lymphoma |
| Malignant lymphoma, small cleaved cell, diffuse |
Non-Hodgkin lymphoma |
| Malignant lymphomatous polyposis |
Mantle cell lymphoma |
| Malignant mastocytosis |
Malignant mastocytosis |
| Malignant melanocytic lesion |
Malignant melanoma |
| malignt melanom, kategori |
Malignant melanoma |
| Malignant melanoma of cornea |
Malignant melanoma of conjunctiva |
| malignt melanom |
Malignant melanoma |
| Malignant myoepithelioma |
Malignant myoepithelioma |
| Malignant neoplasm of bone and articular cartilage |
Primary malignant neoplasm of bone |
| Malignant neoplasm of lymphoid AND/OR histiocytic tissue |
Non-Hodgkin's lymphoma (clinical) |
| Malignant neoplasm of metacarpal bones of foot |
Malignant neoplasm of metatarsal bone of foot (disorder) |
| malign tumör i mellanlob i lunga |
Malignant neoplasm of middle lobe of right lung (disorder) |
| Malignant neoplasms (& carcinoma) |
Carcinoma (morphologic abnormality) |
| Malignant neoplasms (& carcinoma) |
Carcinoma (morphologic abnormality) |
| Malignant neoplastic process |
Neoplasm, benign |
| malign nervskidetumör, kategori |
Malignant nerve sheath tumour |
| malignt teratom, kategori |
Malignant teratoma (morphologic abnormality) |
| Malignant tumour of body of uterus |
Malignant neoplasm of body of uterus (disorder) |
| Malignant tumour of endocrine gland |
Malignant neoplasm of endocrine gland (disorder) |
| Malignant tumour of nervous system |
Malignant neoplasm of nervous system (disorder) |
| Malignant tumour of skin |
Malignant neoplasm of skin (disorder) |
| Malignant tumour of soft tissue of lower limb |
Primary malignant neoplasm of soft tissues of lower limb |
| Malignant tumour of soft tissue of upper limb |
Primary malignant neoplasm of soft tissues of upper limb (disorder) |
| Malignant, metastatic site |
Neoplasm, metastatic |
| Malignant, uncertain whether primary or metastatic site |
Neoplasm, malignant, uncertain whether primary or metastatic |
| simulant |
Malingering |
| Malingering |
Malingering |
| klinisk handläggningsplan för undernäring |
Malnutrition clinical management plan (record artifact) |
| Malocclusion |
Malocclusion of teeth |
| Malocclusion due to finger habits |
Malocclusion due to sucking habits |
| Malposition of fetus |
Malpresentation of fetus |
| Mammalian type C oncovirus group |
Mammalian group Gammaretroviruses (organism) |
| Mammography assessment scale 0 (out of 5) - Additional imaging needed |
Mammography assessment (Category 0) - Need additional imaging evaluation (finding) |
| Mammography assessment scale 1 (out of 5) - Negative |
Mammography assessment (Category 1) - Negative (finding) |
| Mammography assessment scale 2 (out of 5) - Benign |
Mammography assessment (Category 2) - Benign finding (finding) |
| Mammography assessment scale 3 (out of 5) - Probably benign |
Mammography assessment (Category 3) - Probably benign finding, short interval follow-up (finding) |
| Mammography assessment scale 4 (out of 5) - Abnormality suspicious for malignancy |
Mammography assessment (Category 4) - Suspicious abnormality, biopsy should be considered (finding) |
| Mammography assessment scale 5 (out of 5) - Highly suggestive of malignancy |
Mammography assessment (Category 5) - Highly suggestive of malignancy (finding) |
| Mammography assessment scale finding |
Mammography assessment finding (finding) |
| mangafodipirtrinatrium 50 mikromol/ml, injektionsvätska, lösning |
Product containing only mangafodipir in parenteral dose form (medicinal product form) |
| Manipulation and application of cast or splint |
Procedure by method |
| Manipulation of neck or trunk |
Musculoskeletal system manipulation |
| mannitol 10 %, infusionsvätska, lösning, flaska |
Product containing only mannitol in parenteral dose form (medicinal product form) |
FHIR